* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Expression of Differentiated Function by
Cell growth wikipedia , lookup
Extracellular matrix wikipedia , lookup
Cell culture wikipedia , lookup
Cell encapsulation wikipedia , lookup
Cellular differentiation wikipedia , lookup
Organ-on-a-chip wikipedia , lookup
Tissue engineering wikipedia , lookup
[CANCER RESEARCH 30, 127-132, January 1970] Expression of Differentiated Function by Mammary Carcinoma Cells in Vitro1 Roger W. Turkington and Marie Riddle Department of Medicine, Duke University Medical Center, Durham, North Carolina 27706, and the Division of Endocrinology, Administration Hospital, Durham, North Carolina 27705 SUMMARY Expiants of C3H mouse and rat R3230AC mammary carcinomas were cultured in the presence of insulin, hydrocortisone, and prolactin in order to test the ability of these cells to differentiate into cells producing specialized cell products. Although normal epithelial cells differentiate into alveolar secretory cells which synthesize casein, a-lactalbumin, and lactose synthetase A protein, C3H carcinoma cells fail to produce significant increases in these differentiated functions under the in vitro conditions. This failure is unrelated to rapid proliferation since the C3H carcinoma cells proliferate at a rate similar to that of normal cells and the rapidly proliferating R3230AC carcinoma cells can markedly increase casein synthesis in response to hormonal stimuli in vitro. The results support the concept that cells which form C3H tumors cannot limit the cell population size through the normal sequence of cell differentiation. INTRODUCTION The formation of a tumor by some neoplastic cells would appear to result from the high rate of cell division among such cells. It is recognized however that many types of cancer cells divide less often than some normal cells (1, 9, 15). One possible explanation for tumor formation by slowly proliferating cells could lie in the potential inability of such cells to differentiate. While normal populations of continuously proliferating cells are constantly renewed by frequent stem-cell division, the size of such cell populations is limited by the production of daughter cells which can synthesize highly differentiated cell products and which seldom divide. Although specialized cell products may be formed by some cancer cells, many types of neoplastic cells exhibit little functional evidence of differentiation. These latter cells are often designated "dedifferentiated" cells, but no evidence exists that they have in fact lost the capacity to synthesize specialized proteins. In order to test neoplastic cells for their capacity to synthesize specialized proteins we have studied milk protein 'This work was supported by USPHS Grant CA-10268 from the National Cancer Institute, NIH. Received March 6, 1969; accepted May 21, 1969. Veterans synthesis by mammary carcinoma cells. Previous studies established that normal mouse mammary epithelial cells form casein, a-lactalbumin, and the A protein of lactose synthetase in response to specific hormonal stimuli. Epithelial cells which divide in the presence of insulin and hydrocortisone in organ culture produce daughter cells which can synthesize these milk proteins in response to stimulation by prolactin and insulin (22, 24, 26). Cells formed in the presence of insulin alone do not express such new genetic information. Since mammary cell differentiation is dependent upon hormonal stimulation the ability of mammary carcinoma cells to differentiate can be assayed by allowing these cells to grow in the requisite hormonal environment. MATERIALS AND METHODS Organ Cultures. The carcinomas studied were the spontaneous, virus-associated carcinoma in the C3H/HeJ mouse and the R3230AC transplantable carcinoma in the Fischer rat. Lactational, midpregnancy, and neoplastic mammary tissues were prepared and incubated in Medium 199 (Microbiological Associates, Bethesda, Md.) as previously described (23). Each hormone was present in the medium at a concentration of 5 jug/ml. Casein Synthesis. The rate of casein synthesis was measured by allowing the expiants to incorporate 32P (carrier-free, 60 ¿iCi/mlmedium) or 14C-labeled amino acids (a mixture of 20 amino acids, 10 juCi/ml medium) during a 4-hr labeling period. The labeled casein was isolated from the 105,000 X g supernatant of tissue homogenates and culture medium by precipitation with rennin and calcium ions in the presence of authentic C3H/HeJ mouse or Fischer rat casein "carrier," and prepared for polyacrylamide gel electrophoresis as described previously (24). A lower gel formed with 7.5% acrylamide and 8 M urea and buffered at pH 8.83 with 0.375 M Tris-HCl provided optimal resolution of each of the components of casein from these 2 species. Potassium persulfate (50 mg/100 ml) and riboflavin (0.5 mg/100 ml) were present as initiators, and a minimal amount of tetramethylethylenediamine was used as accelerator. The upper gel was 5% acrylamide and 8 M urea, and other buffer systems were those of Jovin et al. (IO). The casein preparations were subjected to electrophoresis at 10 ma/tube in a temperature-regulated apparatus at 25°.The gels were then fixed in 7.5% acetic acid, stained with Amido black, and sectioned with a manual slicing device (5) which divided the gels from the origin into uniform slices 1.0 mm JANUARY 1970 Downloaded from cancerres.aacrjournals.org on June 18, 2017. © 1970 American Association for Cancer Research. 127 Roger W. Turkington and Marie Riddle thick. The gel sections were then counted in a liquid scintillation spectrometer with the use of Bray's solution (2). Lactose Synthetase. Galactosyltransferase reactions of the lactose synthetase enzyme system were assayed by the radioactive method described earlier (22) except that uridine triphosphate was present in the assay tubes at a concentration of 2 mM. The A protein galactosyltransferase activity is measured by the rate of galactose-14C transfer from uridine diphosphogalactose to TV-acetylglucosamine. a-Lactalbumin (B protein) modifies the substrate acceptor specificity of this enzyme to include glucose (3) and a-lactalbumin activity is assayed by the rate of galactose-14C transfer to glucose in the presence of an excess of exogenous purified bovine A protein. Other Methods. DNA in the tissues was measured by the method of Burton (4). Cytoplasmic noncasein phosphoprotein was measured by the method of Juergens et al. (11). For measurement of the rates of total cytoplasmic protein, tissues were cut into small expiants and exposed to Medium 199 containing 14C-labeled amino acids (10 /¿Ci/ml)for 3 hr. 14C-Labeled proteins were precipitated from the 1000 X g supernatant with 5% trichloroacetic acid. After hydrolysis of nucleic acids in trichloroacetic acid at 90° for 15 min the precipitates were washed repeatedly with trichloroacetic acid and ether-ethanol, dissolved in 5 M acetic acid, and counted in Bray's scintillation fluid. RESULTS Chart la shows the electrophoretogram radioactivity profile of casein-32? isolated from mammary expiants of a 10-day lactating Fischer rat, the strain of origin of the R3230AC carcinoma. The electrophoretic mobilities of the 9 radioactive peaks observed are identical with those of the stained bands of authentic Fischer rat casein. Similar peaks of casein-32? are formed in small amounts by differentiated midpregnancy epithelial cells incubated in medium containing insulin (Chart 1ft), and, as shown previously (24), a marked stimulation of the synthesis of these casein components occurs in tissue which differentiates in the IFF2 medium. Radioactive peaks representing the synthesis of specific casein phosphoproteins by R323OAC cells incubated on medium containing insulin are shown in Chart le. The rate of incorporation of P into casein per cell, based upon the peak values in each component, is approximately 10% that of the lactational tissue. The rate of synthesis of casein-32? components in tumor cells derived from a lactating donor was approximately 25% of the rate of the mammary cells of the donor. "Chase" experiments revealed no detectable turnover of 32P-labeled casein in any of the tissues studied, indicating that the amount of casein-32? recovered after the 4-hr labeling period reflects the rate of casein formation. Culture of the carcinoma cells in the IF? medium for 48 hr results in a 200% increase in the synthetic rates, and the relative rates of synthesis of the casein components are similar to those observed in the normal 2The abbreviation prolactin medium. 128 used is: IFF, insulin, hydrocortisone, and tissues. That is, although the rate of synthesis of each component is below that in the normal cell, the neoplastic cell maintains the same radioactivity profile or ratio of synthesis among the components which is characteristic of the normal cell. Chart 2a shows the characteristic electrophoretogram radioactivity profile of casein-32? synthesized by lactational C3H/HeJ mouse mammary gland. Chart 2b illustrates a similar stimulation of casein synthesis as a concomitant of cell differentiation in the IF? medium. Synthesis of casein components can be detected in C3H/HeJ carcinomas, as shown in Chart 2c, but the rate of synthesis per cell is markedly below that of the lactational tissue. The radioactivity in the major casein bands (Gel Sections 10 to 27) ranges between 1 and 3% of the lactational values. Although growth in the IF? medium results in slight stimulation of the 3 slowest com ponents, there is no significant stimulation of the peaks contained in Gel Sections 10 to 27, which represent the major proteins characteristic of the differentiated cell (cf. Chart 2a). Inclusion or omission of hormones in the medium just during the 4-hr labeling period did not alter the results shown. Results similar to those depicted in Charts 1 and 2 were also obtained with 14C-labeled amino acids as the radioactive precursor. Another differentiated function, lactose synthesis, was also compared in normal and neoplastic mammary cells by measuring the activity of the terminal and rate-limiting enzyme in the biosynthetic pathway, lactose synthetase. Previous studies (22) demonstrated that both the A protein (galactosyltransferase) and the B protein (a-lactalbumin) of this enzyme system are induced in cells which differentiate in response to insulin, hydrocortisone, and prolactin. Table 1 shows that the A and B protein activities are present in both carcinomas, but the cellular levels are V15 to Vso of those found in the corresponding differentiated cells. Table 2 compares the capacity of normal and neoplastic mammary epithelial cells for hormone-dependent differentiation in terms of the formation of the lactose synthetase proteins. As a consequence of cell division in the IFF medium the A and B protein activities of normal tissues rise 500 to 600% above those observed in expiants incubated on medium containing the single hormone insulin. Although some rise in enzyme activity was observed in the carcinomas incubated on IFF medium, this was only an approximately 50% increase. Experiments were performed in which extracts of the neoplastic and normal cells were mixed and assayed. The results demonstrated that these differences could not be attributed to the presence of an enzyme inhibitor in the neoplasms or to the presence of an activator in the normal cells. In order to determine whether the differences in rates of casein synthesis and in lactose synthetase activity observed between carcinoma and normal cells could relate to corresponding differences in rates of cytoplasmic protein synthesis in general, several other incorporation studies were carried out. The results shown in Table 3 are representative of 3 such experiments. In terms of the rates of 14C-labeled amino acid incorporation into total cytoplasmic protein, it can be seen that the markedly reduced rates of milk protein formation in the carcinoma cells cannot be explained by the CANCER RESEARCH VOL. 30 Downloaded from cancerres.aacrjournals.org on June 18, 2017. © 1970 American Association for Cancer Research. Mammary Carcinoma Cells in Vitro Table 1 Table 3 Activities of the A and B proteins of lactose synthetase in lactational mammary gland and mammary carcinomas Rates of synthesis of total cytoplasmic protein and cytoplasmic noncasein phosphoprotein in expiants of lactational mammary gland and mammary carcinomas The values are the mean ±l S. D. of replicate determinations on 6 tissues in each group. The A and B protein activities were assayed separately in tissue homogenates using the radioactive assay of Brew et al. (3) as described previously (15). The neutral sugar product formed in the tissue homogenates in the presence of uridine diphosphogalactose-14C, glucose, and exogenous purified bovine A protein was shown by paper chromatography to be lactose. Lactose synthetase product/min/20 ¿igDNA) A protein Fischer rat Mammary gland carcinomaC3H R3230AC mouse Mammary gland Carcinoma2.99 B protein Noncasein phosphoprotein Fischer rat Mammary gland R3230AC carcinoma 1250 2360 918 868 C3H mouse Mammary gland Carcinoma 3640 2510 875 600 ±0.42 0.052 ±0.0183.66+0.97 In relation ±1.17 0.292 ±0.0952.45 0.120+0.036 to these observations on rates of milk protein synthesis, studies on concurrent rates of cell proliferation were performed. Table 4 lists indices for labeling of normal and neoplastic cells with thymidine-3H. It was shown previously Effect of various hormones on lactose synthetase activity in expiants of midpregnancy mammary glana ana oj mammary carcinomas Expiants were incubated on Medium 199 containing insulin or IFF for 48 hr, and were then weighed and assayed for enzymatic activity as previously described (15). Since a large proportion of the mam mary gland explant weight represents fat cells, only relative increases in response to hormones are compared in this experiment. The results are representative of 3 such experiments. Fischer rat Mammary gland Total protein ±0.48 ±0.0905.55 0.216 Table 2 Tissue Radioactivity DNA/3 hr) Hormone system Insulin IFF Lactose synthetase (mamóles product/min/mg tissue) A protein B protein 0.007 0.032 0.0120.004 DISCUSSION The important studies previously reported by Huggins et al. (8), Kim and Furth (12-14), and others indicated that several 0.003 0.018 carcinomaC3H R3230AC IFFInsulin that these indices correlate with mitotic indices and thus are a reflection of different rates of cell proliferation rather than merely different rates of uptake of the radioactive precursor (23). Significant numbers of epithelial cells in the developing, midpregnancy gland are in the S period at the beginning of organ culture and, as shown previously, many cells are induced to synthesize DNA in response to the presence of insulin in the medium (11,12). Very few of the highly differentiated cells of lactational tissue are proliferating. Of particular note was the observation that the C3H carcinoma cells proliferated no more rapidly than normal midpregnancy cells. In contrast R3230AC carcinoma cells proliferated most rapidly, with all cells initiating DNA synthesis during the first 24-hr period. 0.0110.002 mouse Mammary glandCarcinomaInsulin IFFInsulin 0.0450.028 0.0150.004 IFF0.010 0.0400.008 0.005 100% increase in the R323OAC cells or the 50% reduction in the C3H carcinoma cells as compared to normal cells. The rate of incorporation of 32P into another population of cytoplasmic proteins, the noncasein phosphoproteins, was also not sufficiently different between the normal and carcinoma cells as to account for the marked differences observed in casein phosphoprotein synthesis. Table 4 Labeling indices of mammary epithelial cells and carcinoma cells during organ culture Expiants were exposed to Medium 199 containing tritiated thymidine (0.5 »jCi/ml)for the indicated periods of culture. The preparation of autoradiographs and determination of the percentage of cell nuclei labeled was previously described (16). Tissue Epithelial 4 hr cells labeled ~^f hr (%) Fischer ratMidpregnancy glandLactationalmammary glandR3230AC mammary carcinomaC3H mouseMidpregnancy glandLactationalmammary glandCarcinoma70.82460.74351004034 mammary JANUARY 1970 Downloaded from cancerres.aacrjournals.org on June 18, 2017. © 1970 American Association for Cancer Research. 129 Roger W. Turkington and Marie Riddle 12,500 1A 10,000 1B 7,500 1500 5,000 1000 2,500 500 1C 1500 o IOOO 5 10 15 20 25 30 GEL SECTION 35 è 500 5 IO IS 20 25 CELSECTION 30 IO 35 15 20 25 30 35 GELSECTION Chart 1. Electrophoretogram radioactivity profiles of casein components labeled with P in vitro by mammary tissues from Fischer rats, a, lactational tissue, labeled 0 to 4 hr on Medium 199 containing insulin, b, midpregnancy tissue culture for 44 hr on Medium 199 containing insulin (o—o) or insulin, hydrocortisone, and prolactin (•—•) and labeled during the 44- to 48-hr period. Since fat cells comprise a large proportion of these expiants, only the relative response per mg tissue is represented, c, carcinoma expiants incubated as in Chart Ib. 2000 20,000 800 2C 1500 600 400 IL o 200 500 15 20 25 GELSECTION 30 35 5 10 15 20 25 GELSECTION 30 35 15 20 25 30 35 GELSECTION Chart 2. Electrophoretogram radioactivity profiles of casein components labeled with 32t P in vitro by mammary tissues from C3H mice. Experiments were performed as in Chart 1. a, lactational tissue; b, midpregnancy tissue; c, carcinoma tissue. types of mammary carcinomas in rats are hormone-depen dent, and that often those hormonal conditions which are most effective in inducing mammary gland growth or secre tion correlate with increased rates of tumor growth in vivo. In contrast the growth patterns of mammary carcinomas in mice have often appeared to be independent of hormonal factors (6). The hormonal dependence or responsiveness of mammary carcinoma ecus may however be more variable than could be predicted from the species of origin alone. Previous studies on the R3230AC carcinoma of the Fischer rat have demonstrated that its cells can induce DNA polymerase, initiate DNA synthesis, and subsequently divide independently of insulin, which is required for a stimulation 130 of these processes in normal Fischer rat mammary epithelial cells (23, 26). Although cell growth in the Fischer rat mammary gland in vitro is profoundly altered by estrogenic hormones it is unaltered by estrogens in the R3230AC carcinoma in vitro (23). In contrast DNA synthesis and cell growth in C3H mouse carcinomas in vitro are modified by insulin and estrogenic hormones in a manner indistinguish able from that in the normal mouse mammary gland (23, 26). The purpose of these studies was to determine another aspect of hormonal responsiveness in these 2 model tumor systems, namely their capacity for hormone-dependent cell differentia tion. In contrast to almost all other tissues of the body, the CANCER RESEARCH VOL. 30 Downloaded from cancerres.aacrjournals.org on June 18, 2017. © 1970 American Association for Cancer Research. Mammary Carcinoma Ceils in Vitro HORMAL observed in the rates at which the normal and neoplastic cells incorporate 14C-labeled amino acids into total cytoplasmic protein or 32P into cytoplasmic noncasein phosphoprotein do DIFFERENTIATED LIFESPAN Chart 3. Scheme of cell proliferation and differentiation in normal and neoplastic mammary cells of the C3H mouse. chemical nature of the molecular inducers of cell differentia tion in the mammary gland are known. In vitro they are insulin, hydrocortisone, and prolactin (11, 21), hormones which cause morphological differentiation and selectively induce milk proteins (22, 25). The milk proteins which have been assayed in these experiments represent specific proteins which normally are synthesized uniquely by differentiated mammary secretory cells. During the hormone-dependent development of the normal glandular tissue the onset of synthesis of these proteins represents the expression of new genetic information, and thus they serve as markers of regulation of specific gene activity (21, 25). Casein is a group of phosphoproteins which are precipitated selectively by rennin and calcium ions. All of the material so isolated from the normal tissues has previously been shown to be electrophoretically identical with authentic Fischer rat or C3H/HeJ mouse casein (24, 27). The phosphoproteins thus isolated from the neoplastic tissues also consist of components whose electrophoretic mobilities are identical with those authentic caseins of their strain of origin, both by protein staining and by radioactivity patterns. a-Lactalbumin in the R323OAC carcinoma has been further characterized by the electrophoretic mobility of the 14C-labeled protein (27). Earlier studies by Hilf (7) on fluid in the R3230AC carcinoma lend further confidence to the interpretation that these specific milk proteins were synthesized in vitro. Hilf reported the presence of casein components in the "milklike" tumor fluid, and Hilf (7) and Shatton et al. (16) reported the presence of low concentrations of lactose in the fluid. The neoplastic cells studied in the present experiments are characterized by a marked reduction in the rate of formation of casein and in the cellular levels of lactose synthetase A protein and a-lactalbumin in comparison to normal differentiated cells. The differences in protein synthesis relate to specialized milk proteins rather than to differences in rates of total protein synthesis. As shown in Table 3 the differences not in themselves account for the much greater differences in rates of milk protein formation which were observed. An increase in the level of differentiated function in the C3H mouse mammary gland is dependent upon cell division (18-20). During the 48-hr incubation period approximately 70% of the epithelial cell nuclei become labeled with tritiated thymidine (17). Undifferentiated cells as a result of hormonal stimulation produce daughter cells which can synthesize specific milk proteins. As shown in Table 4 differentiated lactational cells seldom divide. The proportions of C3H carcinoma cells and midpregnancy mammary epithelial cells which divide during the 48-hr incubation period are similar, a finding which is consistent with the low rates (relative to some other tumors) of cell proliferation in vivo reported by Mendelsohn et al. (15). During each 24-hr period 100% of the R3230AC carcinoma cells initiate DNA synthesis (23), a rate of proliferation which greatly exceeds that of the midpregnancy epithelial cells. R3230AC carcinomas are able to increase their rate of casein synthesis, but milk protein formation is not associated with decreased rates of cell proliferation. The low synthetic rate per cell for casein may on the other hand be viewed as reflecting the direction of more biosynthetic activity toward the processes of cell division. The rate of proliferation per se would not appear to preclude the expression of differentiated function in C3H carcinoma cells however. On the contrary their failure to differentiate may represent a factor in the abnormal growth potential of these cells. This pattern of cell proliferation is shown schematically in Chart 3. Proliferation of normal epithelial stem cells in IFF medium involves the formation of differentiated secretory cells which, because they seldom divide, limit the size of the cell population (it is not known whether such cell divisions result in the formation of 1 or 2 differentiated cells). The experimental evidence for this model has been previously reviewed (21). Since division of C3H mammary carcinoma cells in the IFF medium fails to produce significant numbers of new, fully differentiated, nondividing cells, daughter cells which are produced may retain the capacity of stem cells to divide into 2 new daughter cells, thus leading to the formation of a large aggregate of undifferentiated mammary cells. The low level of differentiated function in the 2 carcinomas may reflect abnormally low rates of milk protein synthesis in a majority of each cell population, or fully differentiated function in a small proportion of the cells. Studies to distinguish between these 2 possibilities are in progress. It is possible that various tumors or various stages of tumor growth may fall into at least 2 classifications: (a) cells which grow more rapidly than normal cells; and (b) cells which cannot limit the size of the cell population by differentiation. Because the molecular inducers of alveolar differentiation of mammary cells are known to be specific hormones, it has been possible to test experimentally the capacity of cells which form C3H carcinomas to differentiate. Although other factors may be important in determining the neoplastic character of the C3H carcinoma cell the present evidence is consistent with the concept that defective mechanisms for hormone-dependent JANUARY 1970 Downloaded from cancerres.aacrjournals.org on June 18, 2017. © 1970 American Association for Cancer Research. 131 Roger W. Turkington and Marie Riddle differentiation may be a basic abnormality mammary carcinoma cell. of the C3H ACKNOWLEDGMENTS We thank Drs. Ian Trayer and Robert L. Hill for a generous gift of purified bovine lactose synthetase A protein. 14. 15. REFERENCES 16. 1. Baserga, R. The Relationship of the Cell Cycle to Tumor Growth and Control of Cell Division: A Review. Cancer Res., 25: 581-595, 1965. 2. Bray, G. A. A Simple Efficient Liquid Scintillator for Counting Aqueous Solutions in a Liquid Scintillation Counter. Anal. Biochem., /: 279-285, 1960. 3. Brew, K., Vanaman, T. C., and Hill, R. L. The Role of a-Lactalbumin and the A Protein in Lactose Synthetase: A Unique Mechanism for the Control of a Biological Reaction. Proc. Nati. Acad. Sei. U. S., 59: 491-497, 1968. 4. Burton, K. A. Study of the Conditions and Mechanism of the Diphenylamine Reaction for the Colorimetrie Estimation of Deoxyribonucleic Acid. Biochem. J., 62: 315-323, 1955. 5. Chrambach, A. Device for Sectioning of Polyacrylamide Gel Cylinders and its Use in Determining Biological Activity in the Sections. Anal. Biochem., 15: 544-548, 1966. 6. Foulds, L. The Histologie Analysis of Mammary Tumors of Mice. J. Nati. Cancer Inst., 17: 783-801, 1956. 7. Hilf, R., Michel, I., and Bell, C. Morphological and Biochemical Studies on Rat Mammary Carcinoma. Recent Progr. Hormone Res., 23: 229-295, 1967. 8. Huggins, C., Moon, R. C., and Morii, S. Extinction of Experi mental Mammary Cancer. I. Estradiol-17(3 and Progesterone. Proc. Nati. Acad. Sei. U. S., 48: 379-386, 1962. 9. Hoffman, J., and Post, J. In Vivo Studies of DNA Synthesis in Human Normal and Tumor Cells. Cancer Res., 27: 898-902, 1967. 10. Jovin, T., Chrambach, A., and Naughton, M. A. An Apparatus for Preparative Temperature-regulated Polyacrylamide Gel Electrophoresis. Anal. Biochem., 9: 351-369, 1964. 11. Juergens, W. G., Stockdale, F. E., Topper, Y. J., and Elias, J. J. Hormone-dependent Differentiation of Mammary Gland In Vitro. Proc. Nati. Acad. Sei. U. S., 54: 629-634, 1965. 12. Kim, U., and Furth, J. Relation of Mammary Tumors to Mammotrophes; I: Induction of Mammary Tumors in Rats. Proc. Soc. Exptl. Biol. Med., 103: 640-642, 1960. 13. Kim, U., and Furth, J. Relation of Mammary Tumors to 132 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. Mammotrophes; II: Hormone Responsiveness of 3-Methylcholanthrene-induced Mammary Carcinomas. Proc. Soc. Exptl. Biol. Med., 103: 643-645, 1960. Kim, U., and Furth, J. Relation of Mammary Tumors to Mammotrophes; III: Hormone Responsiveness of Transplanted Tumors. Proc. Soc. Exptl. Biol. Med., 705. 646-650, 1960. Mendelsohn, M. L., Dohan, F. C., Jr., and Moore, H. A., Jr. Autoradiographic Analysis of Cell Proliferation in Spontaneous Breast Cancer of C3H Mouse. I. Typical Cell Cycle and Timing of DNA Synthesis. J. Nati. Cancer Inst., 25: 477-484, 1960. Shatton, J. B., Morris, H. P., Gruenstein, M., and Weinhouse, S. Enzymes of Lactose Synthesis in Mammary Glands and Mammary Tumors. Proc. Am. Assoc. Cancer Res., 6: 57, 1965. Stockdale, F. E., Juergens, W. G., and Topper, Y. J. A Histological and Biochemical Study of Hormone-dependent Differenti ation of Mammary Gland Tissue in Vitro. Develop. Biol., 13: 266-281, 1966. Stockdale, F. E., and Topper, Y. J. The Role of DNA Synthesis and Mitosis in Hormone-dependent Differentiation. Proc. Nati. Acad. Sci. U. S., 56: 1283-1289, 1966. Turkington, R. W. Androgen Inhibition of Mammary Gland Differentiation in Vitro. Endocrinology, 80: 329-336, 1967. Turkington, R. W. Cation Inhibition of DNA Synthesis in Mammary Epithelial Cells in Vitro. Experientia, 24: 226-228, 1968. Turkington, R. W. Hormone-Dependent Differentiation of Mammary Gland in Vitro. In: A. A. Moscona and A. Monroy (eds.), Current Topics in Developmental Biology, Vol. 3, pp. 199-218. New York: Academic Press, 1968. Turkington, R. W., Brew, K., Vanaman, T. C., and Hill, R. L. The Hormonal Control of Lactose Synthetase in the Developing Mouse Mammary Gland. J. Biol. Chem., 243: 3382-3387, 1968. Turkington, R. W., and Hilf, R. Hormonal Dependence of DNA Synthesis in Mammary Carcinoma Cells In Vitro. Science, 160: 1457-1459, 1968. Turkington, R. W., Juergens, W. G., and Topper, Y. J. Hormonedependent Synthesis of Casein in Vitro. Biochim. Biophys. Acta, 111: 573-576, 1965. Turkington, R. W., Lockwood, D. H., and Topper, Y. J. The Induction of Milk Protein Synthesis in Post-Mitotic Mammary Epithelial Cells Exposed to Prolactin. Biochim. Biophys. Acta, 148: 475-480, 1967. Turkington, R. W., and Ward, O. T. Hormonal Stimulation of RNA Polymerase in Mammary Gland In Vitro. Biochim. Biophys. Acta, 174: 282-301, 1969. Turkington, R. W., and Riddle, M. Acquired Hormonal Depen dence of Milk Protein Synthesis in Mammary Carcinoma Cells. Endocrinology, 84: 1213-1217, 1969. CANCER RESEARCH VOL. 30 Downloaded from cancerres.aacrjournals.org on June 18, 2017. © 1970 American Association for Cancer Research. Expression of Differentiated Function by Mammary Carcinoma Cells in Vitro Roger W. Turkington and Marie Riddle Cancer Res 1970;30:127-132. Updated version E-mail alerts Reprints and Subscriptions Permissions Access the most recent version of this article at: http://cancerres.aacrjournals.org/content/30/1/127 Sign up to receive free email-alerts related to this article or journal. To order reprints of this article or to subscribe to the journal, contact the AACR Publications Department at [email protected]. To request permission to re-use all or part of this article, contact the AACR Publications Department at [email protected]. Downloaded from cancerres.aacrjournals.org on June 18, 2017. © 1970 American Association for Cancer Research.